BETA

4 Amendments of Radan KANEV related to 2020/2071(INI)

Amendment 65 #
Motion for a resolution
Recital B
B. whereas medicines to treat cancer, infections, diabetes and disorders of the nervous system account for more than half of those in short supply;
2020/06/08
Committee: ENVI
Amendment 120 #
Motion for a resolution
Recital D a (new)
Da. whereas there are no harmonised rules in the Union for generic prescription and generic substitution, which leads to considerable imbalances of possible remedies in Member States in cases of shortages of medicines;
2020/06/08
Committee: ENVI
Amendment 626 #
Motion for a resolution
Paragraph 17 a (new)
17a. Notes the need to assess and to promote effective stock management of medicines shortages in cases of “parallel exports” and the potential beneficial effect of generic substitution by pharmacies proved to be deficient in some member states during the spread of the COVID-19 virus;
2020/06/08
Committee: ENVI
Amendment 667 #
Motion for a resolution
Paragraph 18 a (new)
18a. Calls on the Commission and the Member States to adopt a joint position regarding the potential beneficial effect of common policy for medicines shortages action and promotion of generic substitution policy combined with respective limitations in cases where the substitution is not feasible;
2020/06/08
Committee: ENVI